Quarterly report pursuant to Section 13 or 15(d)

Segment Information

v3.22.2.2
Segment Information
 9 Months Ended
Sep. 30, 2022
Segment Reporting [Abstract]  
Segment Information Segment Information
The following table summarizes select operating results for each reportable segment (in millions).
Successor Predecessor Successor Predecessor
Three Months Ended September 30, Three Months Ended September 30, Nine Months Ended September 30, Nine Months Ended September 30,
2022 2021 2022 2021
Revenues
Medical $ 68.7  $ 52.0  $ 195.6  $ 155.6 
Industrial 92.2  92.3  304.3  334.9 
Consolidated Revenues $ 160.9  $ 144.3  $ 499.9  $ 490.5 
Segment (Loss) Income from Operations
Medical $ 0.4  $ 2.6  $ (3.2) $ (0.1)
Industrial (2.5) 12.5  (49.1) 60.2 
Total Segment (Loss) Income from Operations (2.1) 15.1  (52.3) 60.1 
Corporate and other (25.5) (24.0) (83.6) (73.2)
Consolidated Loss from Operations $ (27.6) $ (8.9) $ (135.9) $ (13.1)
The Company’s assets by reportable segment were not included, as this information is not reviewed by, nor otherwise provided to, the chief operating decision maker to make operating decisions or allocate resources.
The following details revenues by geographic region. Revenues generated from external customers are attributed to geographic regions through sales from site locations (i.e., point of origin) (in millions).
Revenues
Successor Predecessor Successor Predecessor
Three Months Ended September 30, Three Months Ended September 30, Nine Months Ended September 30, Nine Months Ended September 30,
2022 2021 2022 2021
North America
Medical $ 63.7  $ 47.3  $ 181.0  $ 141.2 
Industrial 49.7  47.3  141.8  152.2 
Total North America 113.4  94.6  322.8  293.4 
Europe
Medical 5.1  4.7  14.7  14.4 
Industrial 40.9  43.5  152.0  170.2 
Total Europe 46.0  48.2  166.7  184.6 
Asia Pacific
Medical —  —  —  — 
Industrial 1.5  1.5  10.4  12.5 
Total Asia Pacific 1.5  1.5  10.4  12.5 
Total revenues $ 160.9  $ 144.3  $ 499.9  $ 490.5 
The following details revenues by timing of recognition (in millions):
Revenues
Successor Predecessor Successor Predecessor
Three Months Ended September 30, Three Months Ended September 30, Nine Months Ended September 30, Nine Months Ended September 30,
2022 2021 2022 2021
Point in time $ 88.8  $ 103.0  $ 323.0  $ 357.0 
Over time 72.1  41.3  176.9  133.5 
Total revenues $ 160.9  $ 144.3  $ 499.9  $ 490.5 
The following details revenues by product category (in millions):
Revenues
Successor Predecessor Successor Predecessor
Three Months Ended September 30, Three Months Ended September 30, Nine Months Ended September 30, Nine Months Ended September 30,
2022 2021 2022 2021
Medical segment:
Medical $ 68.7  $ 52.0  $ 195.6  $ 155.6 
Industrial segment:
Reactor Safety and Control Systems 23.7  29.4  89.2  109.0 
Radiological Search, Measurement, and Analysis Systems 68.5  62.9  215.1  225.9 
Total revenues $ 160.9  $ 144.3  $ 499.9  $ 490.5